High G2M score tumor was also significantly associated with high gene expression of KRAS and TP53, which are reported to relate with each gene mutation (Figure 3C, p < 0.001 and p = 0.003, respectively), whereas there was no association with SMAD4 and CDKN2A gene expressions. This evidence concerns the gene KRAS and neoplasm.